Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CFR's Adcock Ingram bid uncertain amid local opposition

This article was originally published in Scrip

Executive Summary

A shareholder meeting due to be held on 18 December to vote on a recently improved bid by Chilean firm CFR Pharmaceuticals for South Africa's Adcock Ingram has been postponed until January. The vote has been delayed to give shareholders time to consider a revised offer. CFR will be hoping that it also buys it time to secure the backing of significant Adcock shareholders who have hitherto been hostile to the takeover.


Related Companies




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts